Terms: = Gastric cancer AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Prognosis
18 results:
1. Prognostic effect of categorized tumor deposits in gastric cancer: A single-center retrospective study.
Hayashi M; Abe M; Fujita T; Matsushita H
Surgery; 2024 Feb; 175(2):373-379. PubMed ID: 37940432
[TBL] [Abstract] [Full Text] [Related]
2. Postoperative circulating tumor DNA detection and cblb mutations are prognostic biomarkers for gastric cancer.
Zhou H; Liu H; Li J; Wang J; Fu X; Li Y; Mao S; Du J
Genes Genomics; 2023 Aug; 45(8):1037-1046. PubMed ID: 37306927
[TBL] [Abstract] [Full Text] [Related]
3. [Clinicopathological characteristics and prognosis of patients with sporadic multiple primary gastrointestinal stromal tumors].
Wang T; Zeng XY; Yang WC; Yang M; Fan J; Jia J; Li CG; Liu WZ; Zhang P; Cai KL; Wang GB; Tao KX
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):783-788. PubMed ID: 34530559
[No Abstract] [Full Text] [Related]
4. Differentiated/undifferentiated mixed type is a prognostic factor for T2/T3 gastric cancer patients.
Lu H; Sun Y; Zhu Z; Xu H; Huang R; Huang B
Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1329-1336. PubMed ID: 34431734
[TBL] [Abstract] [Full Text] [Related]
5. From Lauren's diffuse gastric cancer to WHO's poorly cohesive carcinoma. Clinicopathological and prognostic characteristics.
Sarriugarte Lasarte A; García Alberdi E; Martínez Indart L; Gutiérrez Grijalba O; Álvarez Abad I; Guerra Lerma M; Calle Baraja M; Colina Alonso A
Rev Esp Enferm Dig; 2021 May; 113(5):324-331. PubMed ID: 33228367
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic impact of anatomical extent of metastatic lymph node on gastric cancer: a propensity score matching study.
Cheng LJ; Zhou WJ; An TL; Wei ZW; Yuan C; Xiao X; Hao TF; Yin SC; Zhang CH; He YL
Clin Transl Oncol; 2021 Apr; 23(4):773-782. PubMed ID: 32772226
[TBL] [Abstract] [Full Text] [Related]
7. The assessment of the optimal number of examined lymph nodes and prognostic models based on lymph nodes for predicting survival outcome in patients with stage N3b gastric cancer.
Guo S; Shang M; Dong Z; Zhang J; Wang Y; Zhao Y
Asia Pac J Clin Oncol; 2021 Apr; 17(2):e117-e124. PubMed ID: 32762113
[TBL] [Abstract] [Full Text] [Related]
8. High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma.
Zhou CY; Dong YP; Sun X; Sui X; Zhu H; Zhao YQ; Zhang YY; Mason C; Zhu Q; Han SX
Cancer Med; 2018 Nov; 7(11):5525-5533. PubMed ID: 30358133
[TBL] [Abstract] [Full Text] [Related]
9. Outcomes of Advanced gastric cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
Fanotto V; Uccello M; Pecora I; Rimassa L; Leone F; Rosati G; Santini D; Giampieri R; Di Donato S; Tomasello G; Silvestris N; Pietrantonio F; Battaglin F; Avallone A; Scartozzi M; Lutrino ES; Melisi D; Antonuzzo L; Pellegrino A; Ferrari L; Bordonaro R; Vivaldi C; Gerratana L; Bozzarelli S; Filippi R; Bilancia D; Russano M; Aprile G
Oncologist; 2017 Dec; 22(12):1463-1469. PubMed ID: 28860412
[TBL] [Abstract] [Full Text] [Related]
10. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.
Fanotto V; Cordio S; Pasquini G; Fontanella C; Rimassa L; Leone F; Rosati G; Santini D; Giampieri R; Di Donato S; Tomasello G; Silvestris N; Pietrantonio F; Battaglin F; Avallone A; Scartozzi M; Lutrino ES; Melisi D; Antonuzzo L; Pellegrino A; Torri V; Aprile G
Gastric Cancer; 2017 Sep; 20(5):825-833. PubMed ID: 28028664
[TBL] [Abstract] [Full Text] [Related]
12. A Novel Prediction Model of prognosis After Gastrectomy for gastric Carcinoma: Development and Validation Using Asian Databases.
Woo Y; Son T; Song K; Okumura N; Hu Y; Cho GS; Kim JW; Choi SH; Noh SH; Hyung WJ
Ann Surg; 2016 Jul; 264(1):114-20. PubMed ID: 26945155
[TBL] [Abstract] [Full Text] [Related]
13. Relationship between imatinib trough concentration and outcomes in the treatment of advanced gastrointestinal stromal tumours in a real-life setting.
Bouchet S; Poulette S; Titier K; Moore N; Lassalle R; Abouelfath A; Italiano A; Chevreau C; Bompas E; Collard O; Duffaud F; Rios M; Cupissol D; Adenis A; Ray-Coquard I; Bouché O; Le Cesne A; Bui B; Blay JY; Molimard M
Eur J Cancer; 2016 Apr; 57():31-8. PubMed ID: 26851399
[TBL] [Abstract] [Full Text] [Related]
14. Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer.
Tsukada T; Fushida S; Harada S; Terai S; Yagi Y; Kinoshita J; Oyama K; Tajima H; Fujita H; Ninomiya I; Fujimura T; Ohta T
J Exp Clin Cancer Res; 2011 Nov; 30(1):107. PubMed ID: 22078265
[TBL] [Abstract] [Full Text] [Related]
15. [Economic evaluation of capecitabine use as first line treatment in patients with advanced gastric carcinoma in Portugal].
Macedo A; Pereira C; Gonçalves J; Sousa C
Acta Med Port; 2009; 22(6):827-32. PubMed ID: 20350467
[TBL] [Abstract] [Full Text] [Related]
16. Risk factors for metachronous gastric cancer in the remnant stomach after early cancer surgery.
Nozaki I; Nasu J; Kubo Y; Tanada M; Nishimura R; Kurita A
World J Surg; 2010 Jul; 34(7):1548-54. PubMed ID: 20217411
[TBL] [Abstract] [Full Text] [Related]
17. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract] [Full Text] [Related]
18. Quantification of serum-soluble HLA class I antigens in patients with gastric cancer.
Shimura T; Hagihara M; Yamamoto K; Takebe K; Munkhbat B; Ogoshi K; Mitomi T; Nagamachi Y; Tsuji K
Hum Immunol; 1994 Jul; 40(3):183-6. PubMed ID: 7960961
[TBL] [Abstract] [Full Text] [Related]
